logo
16:01 Mar 06

Samrat Pharmachem Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
203.00
-5.55 (-2.66%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Samrat Pharmachem Ltd. Financials

Samrat Pharmachem Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
203.00
-5.55 (-2.66%)
16:01 Mar 06
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

29/100
Expensive Valuation

Technical

27/100
Technically Bearish

Strength

6

Weakness

9

Opportunity

0

Threats

0

9.90 %

ROE %

5.85 %

ROA %

0.00

EPS

232.38

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
179.02 221.81 310.65 281.58 285.86
Operating Expenses +
170.35 197.48 286.72 279.11 275.63
Raw Material
162.02 190.23 288 265.48 269.27
Increase Decrease in Cost
2.23 -0.33 -10.14 4.84 -2.52
Other Manufacturing Expense
2.86 3.77 4.01 3.58 3.84
Employee Cost
1.5 1.77 1.88 2.22 2.22
Miscellaneous Expenses
1.74 2.04 2.97 2.99 2.82
Operating Profit
8.67 24.33 23.93 2.47 10.23
Other Income
0.46 0.55 0.48 1.38 0.97
Depreciation
0.49 0.59 0.64 0.65 0.65
Interest
1.28 0.67 1.23 0.69 0.67
Profit before tax and exceptio..
7.36 23.62 22.53 2.52 9.89
Exceptional Items
-0.02 -0.02 0 0 0
PBT
7.34 23.6 22.53 2.52 9.89
Provision for Taxation
2.01 6.42 5.9 0.36 2.77
Net Profit
5.33 17.18 16.63 2.16 7.11
NET Profit after MI
0 0 0 0 0
EPS
17.26 55.62 53.83 7 23.02
Operating Profit Margin (%)
4.84 10.97 7.7 0.88 3.58
Net Profit Margin (%)
2.98 7.75 5.35 0.77 2.49

Samrat Pharmachem Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 49.10 49.10 49.10 49.10 49.10 49.00
FII 3.20 3.20 0.00 3.20 3.20 3.20
Public 0.00 0.00 3.20 0.00 0.00 0.30
Others 47.70 47.70 47.70 47.70 47.70 47.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: